Quality of life after the initial treatment of atrial fibrillation with cryoablation versus drug therapy

• Published in: Heart rhythm Vol. 19; no. 2; pp. 197 - 205
• Main Authors: Wazni, Oussama, Dandamudi, Gopi, Sood, Nitesh, Hoyt, Robert, Tyler, Jaret, Durrani, Sarfraz, Niebauer, Mark, Makati, Kevin, Halperin, Blair, Gauri, Andre, Morales, Gustavo, Shao, Mingyuan, Pouliot, Erika, Kaplon, Rachelle E., Nissen, Steven E.
• Format: Journal Article
• Language: English
• Published: United States Elsevier Inc 01.02.2022
• Subjects: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Arrhythmia Agents - therapeutic use; Antiarrhythmic drug therapy; Atrial Fibrillation - drug therapy; Atrial Fibrillation - surgery; Catheter ablation; Cryoablation; Cryoballoon; Cryosurgery; Female; Humans; Male; Middle Aged; Quality of Life; Symptoms; Cryoablation; Cryoballoon; Catheter ablation; Symptoms; Antiarrhythmic drug therapy; Quality of life

The STOP AF First trial recently demonstrated that initial treatment with cryoballoon ablation (CBA) is safe and superior to antiarrhythmic drug (AAD) therapy for preventing atrial arrhythmia recurrence in patients with symptomatic atrial fibrillation (AF). The purpose of this study was to evaluate...